All HRT use raises risk of ovarian cancer

07/15/2009 | Reuters

Hormone replacement therapy raises the risk of ovarian cancer regardless of the type of hormones used or the length of usage, according to a study from Denmark that included some 900,000 women. Researchers found that women taking HRT during the study follow-up period had almost a 40% increased chance of developing ovarian tumors.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC